Dr. Hönle AG
Dr. Hönle AG (0O27.L) Stock Overview
Explore Dr. Hönle AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
55.4M
P/E Ratio
-4.26
EPS (TTM)
$-0.68
ROE
-0.15%
0O27.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Dr. Hönle AG (0O27.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.72.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.26 and a market capitalization of 55.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
Markus Arendt
585
Nicolaus-Otto-Str. 2, Munich
2012